# Chiglitazar/Metformin in Non-obese Women With PCOS

> **NCT06125587** · PHASE2,PHASE3 · COMPLETED · sponsor: **Shengjing Hospital** · enrollment: 55 (actual)

## Conditions studied

- Polycystic Ovary Syndrome
- Chiglitazar
- Metformin

## Interventions

- **DRUG:** Chiglitazar
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT06125587
- **Lead sponsor:** Shengjing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-15
- **Primary completion:** 2024-10-31
- **Final completion:** 2024-11-20
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2025-01-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06125587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06125587, "Chiglitazar/Metformin in Non-obese Women With PCOS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06125587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*